1147 related articles for article (PubMed ID: 24150415)
1. Delivery materials for siRNA therapeutics.
Kanasty R; Dorkin JR; Vegas A; Anderson D
Nat Mater; 2013 Nov; 12(11):967-77. PubMed ID: 24150415
[TBL] [Abstract][Full Text] [Related]
2. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.
Kim B; Park JH; Sailor MJ
Adv Mater; 2019 Dec; 31(49):e1903637. PubMed ID: 31566258
[TBL] [Abstract][Full Text] [Related]
3. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
[TBL] [Abstract][Full Text] [Related]
4. Synthetic SiRNA Delivery: Progress and Prospects.
Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
[TBL] [Abstract][Full Text] [Related]
5. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
Meade BR; Dowdy SF
Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
7. SiRNA delivery: challenges and role of carrier systems.
Shegokar R; Al Shaal L; Mishra PR
Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
[TBL] [Abstract][Full Text] [Related]
8. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
Subhan MA; Torchilin VP
Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
Aghamiri S; Mehrjardi KF; Shabani S; Keshavarz-Fathi M; Kargar S; Rezaei N
Nanomedicine (Lond); 2019 Aug; 14(15):2083-2100. PubMed ID: 31368405
[TBL] [Abstract][Full Text] [Related]
10. The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy.
Khelghati N; Soleimanpour Mokhtarvand J; Mir M; Alemi F; Asemi Z; Sadeghpour A; Maleki M; Samadi Kafil H; Jadidi-Niaragh F; Majidinia M; Yousefi B
Chem Biol Drug Des; 2021 Apr; 97(4):997-1015. PubMed ID: 33458952
[TBL] [Abstract][Full Text] [Related]
11. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
Joo MK; Yhee JY; Kim SH; Kim K
J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Engineering Carriers for siRNA Delivery.
Yang C; Lin ZI; Zhang X; Xu Z; Xu G; Wang YM; Tsai TH; Cheng PW; Law WC; Yong KT; Chen CK
Macromol Biosci; 2024 Apr; 24(4):e2300362. PubMed ID: 38150293
[TBL] [Abstract][Full Text] [Related]
13. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of siRNA delivery by nanoparticles.
Yuan X; Naguib S; Wu Z
Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
[TBL] [Abstract][Full Text] [Related]
15. Biomaterials in siRNA Delivery: A Comprehensive Review.
Ho W; Zhang XQ; Xu X
Adv Healthc Mater; 2016 Nov; 5(21):2715-2731. PubMed ID: 27700013
[TBL] [Abstract][Full Text] [Related]
16. Strategies, design, and chemistry in siRNA delivery systems.
Dong Y; Siegwart DJ; Anderson DG
Adv Drug Deliv Rev; 2019 Apr; 144():133-147. PubMed ID: 31102606
[TBL] [Abstract][Full Text] [Related]
17. Effect of nanoparticle conjugation on gene silencing by RNA interference.
Singh N; Agrawal A; Leung AK; Sharp PA; Bhatia SN
J Am Chem Soc; 2010 Jun; 132(24):8241-3. PubMed ID: 20518524
[TBL] [Abstract][Full Text] [Related]
18. Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery.
Whitehead KA; Sahay G; Li GZ; Love KT; Alabi CA; Ma M; Zurenko C; Querbes W; Langer RS; Anderson DG
Mol Ther; 2011 Sep; 19(9):1688-94. PubMed ID: 21750531
[TBL] [Abstract][Full Text] [Related]
19. Matrix systems for siRNA delivery.
Naeye B; Raemdonck K; Remaut K; Demeester J; De Smedt SC
Curr Top Med Chem; 2012; 12(2):89-96. PubMed ID: 22196275
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular assemblies in functional siRNA delivery: where do we stand?
Aliabadi HM; Landry B; Sun C; Tang T; Uludağ H
Biomaterials; 2012 Mar; 33(8):2546-69. PubMed ID: 22209641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]